Opus Genetics (IRD) Return on Sales (2010 - 2026)

Opus Genetics (IRD) has 9 years of Return on Sales data on file, last reported at 0.3% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.3%, down 29.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.09% (down 5.0% YoY), and the FY2025 annual result was 0.03%, up 2.0% from the prior year.
• Return on Sales fell to 0.3% in Q1 2026 per IRD's latest filing, from 0.04% in the prior quarter.
• Over five years, Return on Sales peaked at 0.01% in Q4 2022 and troughed at 0.45% in Q2 2022.
• A 5-year average of 0.1% and a median of 0.04% in 2024 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2022 and 2026: Return on Sales jumped 97 bps in 2022, then declined 29 bps in 2026.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2022, then plunged by 433 bps to 0.03% in 2023, then tumbled by 188 bps to 0.08% in 2024, then jumped by 48 bps to 0.04% in 2025, then sank by 611 bps to 0.3% in 2026.
• Business Quant data shows IRD's Return on Sales at 0.3% in Q1 2026, 0.04% in Q4 2025, and 0.06% in Q3 2025.